Skip to main content
NOVAVAX INC logo

NOVAVAX INC — Investor Relations & Filings

Ticker · NVAX ISIN · US6700024010 LEI · 529900J4GJHPEPQ23205 US Manufacturing
Open in API
Filings indexed 1,095 across all filing types
Latest filing 2013-06-10 Director's Dealing
Country US United States of America
Listing US NVAX

About NOVAVAX INC

https://www.novavax.com/?locale=US

Novavax Inc. is a biotechnology company that develops and commercializes vaccines to prevent serious infectious diseases. The company utilizes a proprietary, protein-based vaccine technology platform, which includes its novel Matrix-M™ adjuvant, to create its vaccine candidates. Its primary commercial product is a protein-based COVID-19 vaccine, Nuvaxovid™. Novavax's research and development pipeline is focused on addressing significant health needs, including influenza and a combination COVID-19-influenza vaccine. The company's strategy emphasizes advancing its pipeline assets and establishing strategic partnerships to maximize the global health impact of its technology.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2013-06-10 English
FORM 4 SUBMISSION
Director's Dealing
2013-06-10 English
FORM 8-K
M&A Activity Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce significant events. The content describes a public offer to acquire shares of another company (Isconova AB), detailing the terms of the offer, conditions, and related shareholder undertakings. It also references an investor presentation attached as an exhibit and mentions future filings such as a Registration Statement on Form S-4. The document is not a full financial report, earnings release, or management discussion but rather an announcement of a merger-related transaction and tender offer. This fits the category of M&A Activity (TAR), which covers announcements and documents related to merger proposals or takeover bids. The document length is substantial and contains detailed information about the transaction, not just a brief announcement or a regulatory filing. Therefore, the correct classification is TAR with high confidence.
2013-06-04 English
425 Filing
M&A Activity Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report pursuant to the Securities Exchange Act of 1934. The content focuses on the announcement of a public tender offer to acquire outstanding shares of another company (Isconova AB), detailing the terms of the offer, conditions for completion, and related shareholder undertakings. It also references a related investor presentation and press releases attached as exhibits. The document is not a full financial report, earnings release, or management discussion but rather an announcement of a significant corporate transaction event. This fits the category of M&A Activity (TAR), which covers announcements and documents related to merger proposals or takeover bids. The length and detail confirm it is not a brief announcement or a regulatory filing fallback. Therefore, the classification is TAR with high confidence.
2013-06-04 English
FORM 10-Q
Interim / Quarterly Report Q1 2013
2013-05-09 English
FORM 8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 7, 2013, by Novavax, Inc. It announces the issuance of a press release regarding financial results for the quarter ended March 31, 2013, and mentions a conference call discussing those results. The document itself does not contain detailed financial statements or substantive financial data but rather furnishes the press release as an exhibit. The text explicitly states that the information is furnished and not filed, indicating this is an announcement of financial results rather than the results themselves. Given the nature of the document as a current report announcing financial results and a conference call, it fits best under the category of Earnings Release (ER), which covers initial announcements of quarterly financial results with key highlights only.
2013-05-07 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.